NexgenRx (NXG) Stock Chart & Stock Price History C$0.37 0.00 (0.00%) As of 08/21/2025 02:45 PM Eastern Add Compare Share Share Chart Stock AnalysisChartBuy This Stock NexgenRx Stock Price Performance The NexgenRx (NXG) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 54.17%, with a year-to-date return of 34.55%. In the past month, the stock has increased 2.78%, reflecting recent market activity. As of the latest close, NexgenRx traded at C$0.37 with a market cap of C$26.24 million and volume of 165,500 shares. Five years ago, the stock traded at C$0.19, representing a 100.00% increase over that period. At the time, it had a market cap of C$11.19 million and a volume of 46,500 shares. Receive NXG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+2.78%3 Month Performance+23.33%Year-To-Date Performance+34.55%1 Year Performance+54.17%5 Year Performance+100.00% NXG Stock Chart for Friday, August, 22, 2025 NXG Chart by TradingView NexgenRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025C$0.37C$0.37C$0.39C$0.37165,500 shsC$26.24 million08/20/2025C$0.37C$0.37C$0.37C$0.3740,100 shsC$26.24 million08/19/2025C$0.37C$0.37C$0.37C$0.3720,000 shsC$26.24 million08/18/2025C$0.37C$0.37C$0.37C$0.3720,000 shsC$26.24 million08/15/2025C$0.37C$0.37C$0.37C$0.3720,000 shsC$26.24 million08/14/2025C$0.37C$0.37C$0.37C$0.3720,000 shsC$26.24 million08/13/2025C$0.37C$0.37C$0.37C$0.3720,000 shsC$26.24 million08/12/2025C$0.37C$0.37C$0.37C$0.372,000 shsC$26.24 million08/11/2025C$0.37C$0.37+1.37%C$0.37C$0.372,000 shsC$26.24 million08/08/2025C$0.37C$0.37C$0.37C$0.37906 shsC$25.89 million Get the Latest News and Ratings for NXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025C$0.35C$0.37+4.29%C$0.37C$0.37906 shsC$25.89 million08/06/2025C$0.35C$0.35C$0.36C$0.3520,000 shsC$24.82 million08/05/2025C$0.35C$0.35C$0.36C$0.3520,000 shsC$24.82 million08/04/2025C$0.35C$0.35C$0.36C$0.3520,000 shsC$24.82 million08/01/2025C$0.35C$0.35C$0.36C$0.3520,000 shsC$24.82 million07/31/2025C$0.35C$0.35C$0.36C$0.3520,000 shsC$24.82 million07/30/2025C$0.34C$0.35+2.94%C$0.36C$0.3520,000 shsC$24.82 million07/29/2025C$0.34C$0.34C$0.34C$0.341,000 shsC$24.11 million07/28/2025C$0.34C$0.34C$0.34C$0.341,000 shsC$24.11 million07/25/2025C$0.34C$0.34C$0.34C$0.341,000 shsC$24.11 million07/24/2025C$0.36C$0.34-5.56%C$0.34C$0.34500 shsC$24.11 million07/23/2025C$0.36C$0.36C$0.36C$0.367,500 shsC$25.53 million07/22/2025C$0.36C$0.36C$0.36C$0.367,500 shsC$25.53 million07/21/2025C$0.39C$0.36-6.49%C$0.36C$0.3615,225 shsC$25.53 million Related Companies ONC Stock Chart ZEN Stock Chart QIPT Stock Chart SUGR Stock Chart MDNA Stock Chart COV Stock Chart APS Stock Chart HBP Stock Chart MDP Stock Chart SVA Stock Chart Receive NXG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:NXG) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access